Achema middle east

Yuvraj

Syntegon Reports Strong Q3 2025 Growth and Margin Expansion

Syntegon Delivers Strong Growth and Margin Expansion in Q3 2025 with Accelerating Pharma Momentum and Profitability Gains Across All Segments Q3 sales increased by...

Australian Biopharma to Expand US Plasma-Derived Therapies

The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the...

API China – The Pharmaceutical Ingredients Exhibition Concludes

API China, the first and longest-running pharmaceutical ingredients exhibition in China brought in over 30,000 visitors and around 1,200 exhibitors between 12 and 14...

Pfizer to Acquire Metsera in a $10bn Deal as Board Backs

The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based...

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country. The...

Sofinnova Partners Raises $750mn to Support Biotech Startups

European venture capital firm Sofinnova Partners said on November 17 that it raised 650 million euros, equivalent to $750 million, for a new fund...

J&J Buys Halda for $3bn to Own the Cell Death Platform

Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »